-
Otsuka Pharmaceutical Co., Ltd. et al v. Accord Healthcare Inc. DC
- 1:19-cv-01987
- D. Del.
- Judge: Leonard P. Stark
- Filed: 10/18/2019
- Closed: 02/03/2022
- Latest Docket Entry: 02/04/2022
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
6
Accused
Products
5
Patents-in-Suit
840
Days in
Litigation
-
Otsuka Pharmaceutical Co., Ltd. et al v. Accord Healthcare Inc. DC
- 1:19-cv-01987
- D. Del.
- Judge: Leonard P. Stark
- Filed: 10/18/2019
- Closed: 02/03/2022
- Latest Docket Entry: 02/04/2022
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Accord Healthcare Incorporated
- 4 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic brexpiprazole tablets, 0.25 mgGeneric brexpiprazole tablets, 0.5 mgGeneric brexpiprazole tablets, 1 mgGeneric brexpiprazole tablets, 2 mgGeneric brexpiprazole tablets, 3 mgGeneric brexpiprazole tablets, 4 mg | US 10,307,419 B2 | All Asserted Claims |
Infringement
Entry 16
|
| Generic brexpiprazole tablets, 0.25 mgGeneric brexpiprazole tablets, 0.5 mgGeneric brexpiprazole tablets, 1 mgGeneric brexpiprazole tablets, 2 mgGeneric brexpiprazole tablets, 3 mgGeneric brexpiprazole tablets, 4 mg | US 8,349,840 B2 | All Asserted Claims |
Infringement
Entry 16
|
| Generic brexpiprazole tablets, 0.25 mgGeneric brexpiprazole tablets, 0.5 mgGeneric brexpiprazole tablets, 1 mgGeneric brexpiprazole tablets, 2 mgGeneric brexpiprazole tablets, 3 mgGeneric brexpiprazole tablets, 4 mg | US 8,618,109 B2 | All Asserted Claims |
Infringement
Entry 16
|
| Generic brexpiprazole tablets, 0.25 mgGeneric brexpiprazole tablets, 0.5 mgGeneric brexpiprazole tablets, 1 mgGeneric brexpiprazole tablets, 2 mgGeneric brexpiprazole tablets, 3 mgGeneric brexpiprazole tablets, 4 mg | US 9,839,637 B1 | All Asserted Claims |
Infringement
Entry 16
|
